Tempus AI (NASDAQ:TEM) Cut to Hold at Stifel Nicolaus

Stifel Nicolaus lowered shares of Tempus AI (NASDAQ:TEM) from a buy rating to a hold rating in a research report released on Monday, MarketBeat reports. They currently have $65.00 price target on the stock, up from their previous price target of $45.00.

Several other equities analysts have also issued reports on TEM. Piper Sandler began coverage on shares of Tempus AI in a report on Monday, August 12th. They issued a “neutral” rating and a $40.00 price target on the stock. Bank of America lowered shares of Tempus AI from a “buy” rating to a “neutral” rating and lifted their price target for the stock from $45.00 to $60.00 in a report on Wednesday, October 2nd. Needham & Company LLC reaffirmed a “buy” rating and issued a $47.00 price target on shares of Tempus AI in a report on Wednesday, August 7th. Loop Capital lifted their price target on shares of Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a report on Tuesday, October 15th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, Tempus AI has an average rating of “Moderate Buy” and an average target price of $54.22.

Tempus AI Price Performance

Shares of NASDAQ:TEM opened at $68.08 on Monday. Tempus AI has a 52 week low of $22.89 and a 52 week high of $79.49. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The business has a 50 day simple moving average of $51.19.

Institutional Investors Weigh In On Tempus AI

A number of large investors have recently made changes to their positions in TEM. NEA Management Company LLC purchased a new stake in Tempus AI in the second quarter valued at $160,048,000. Novo Holdings A S purchased a new stake in Tempus AI in the second quarter valued at $142,605,000. Revolution Growth Management Company Inc. purchased a new stake in Tempus AI in the second quarter valued at $128,133,000. ARK Investment Management LLC boosted its holdings in Tempus AI by 355.0% in the third quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock valued at $134,604,000 after purchasing an additional 1,855,459 shares during the last quarter. Finally, Alphabet Inc. purchased a new stake in Tempus AI in the second quarter valued at $54,289,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.